Free Trial
ETR:SBS

Stratec (SBS) Stock Price, News & Analysis

€41.30
-0.20 (-0.48%)
(As of 07/26/2024 ET)
Today's Range
€40.65
€41.55
50-Day Range
€41.40
€48.30
52-Week Range
€36.00
€69.00
Volume
3,179 shs
Average Volume
6,253 shs
Market Capitalization
$502.21 million
P/E Ratio
41.30
Dividend Yield
1.33%
Price Target
N/A
SBS stock logo

About Stratec Stock (ETR:SBS)

Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. The company operates through three segments: Instrumentation, Diatron, and Smart Consumables. The Instrumentation segment designs and manufactures automated analyzer systems, including service parts and consumables for clinical diagnostics and biotechnology customers. The Diatron segment offers systems, system components, consumables, and tests for the low throughput segment. The Smart Consumables segment develops and manufactures smart consumables in the fields of diagnostics, life sciences, and medical technologies. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.

SBS Stock Price History

SBS Stock News Headlines

I’m giving you the name of this investment for free
This key unlocks a new pathway to wealth that has been kept hidden from you for decades. In my new documentary I will provide you with all the details of this one-of-a-kind investment.
EQS-News: STRATEC POSTS RESULTS FOR FIRST QUARTER OF 2024
Stratec Full Year 2023 Earnings: Misses Expectations
I’m giving you the name of this investment for free
This key unlocks a new pathway to wealth that has been kept hidden from you for decades. In my new documentary I will provide you with all the details of this one-of-a-kind investment.
EQS-News: STRATEC REPORTS RESULTS FOR 2023 FINANCIAL YEAR
Stratec (ETR:SBS) Is Reducing Its Dividend To €0.55
Stratec SE SBS
EQS-News: STRATEC REPORTS RESULTS FOR FIRST NINE MONTHS OF 2023
See More Headlines
Receive SBS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Stratec and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Devices
Sub-Industry
Utilities
CIK
N/A
Fax
N/A
Employees
12,500
Year Founded
N/A

Profitability

Net Income
$12.14 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$252.30 million
Cash Flow
€1.73 per share
Book Value
€18.86 per share

Miscellaneous

Free Float
N/A
Market Cap
$502.21 million
Optionable
Not Optionable
Beta
0.11
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

  • Mr. Marcus Wolfinger (Age 57)
    Chairman of Board of Management & CEO
    Comp: $1.13M
  • Dr. Robert Siegle (Age 57)
    Director of Finance & Human Resources and Member of Board of Management
    Comp: $914k
  • Dr. Claus Vielsack (Age 57)
    Director of Product Development & Member of Board of Management
    Comp: $710k
  • Mr. Hermann Leistner (Age 78)
    Founder & Advisor
  • Dr. Georg Bauer (Age 51)
    Member of Management Board
  • Mr. Jan Keppeler
    Head of Investor Relations, Sustainability & Corporate Communications
  • Mr. Roland Utz
    Head of Supply Chain Management & Senior VP

SBS Stock Analysis - Frequently Asked Questions

How have SBS shares performed this year?

Stratec's stock was trading at €45.55 on January 1st, 2024. Since then, SBS stock has decreased by 9.3% and is now trading at €41.30.
View the best growth stocks for 2024 here
.

What other stocks do shareholders of Stratec own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Stratec investors own include Great Portland Estates (GPOR), Gogo (GOGO), Depomed (DEPO), Cenovus Energy (CVE), China Hydroelectric Corp Foreign (CHC), Bio-Rad Laboratories (BIO) and Berkshire Hills Bancorp (BHLB).

This page (ETR:SBS) was last updated on 7/27/2024 by MarketBeat.com Staff

From Our Partners